Chan Sub Park

9PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPanel data analysisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 04, 2026
α-Viniferin Induces Intrinsic Apoptosis in Triple-Negative Breast Cancer Cells and Synergizes With SB203580 Independently of p38 Mitogen-Activated Protein Kinase.

|Jul 13, 2023
Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?

Juhyeon Lee, Chan Sub Park, Jeong Hun Oh

|Jul 13, 2023
Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy.

Hyung Jin Kim, Juhyeon Lee, In-Chul Park

|Jun 30, 2023
Breast Cancer Statistics in Korea, 2019.

Jung Eun Choi, Zisun Kim, Chan Sub Park

|Oct 31, 2022
The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer.

Ji Yea Kim, Chan Sub Park, Se-Kyeong Jang

|Feb 26, 2021
Aesthetic Scar-Less Mastectomy and Breast Reconstruction.

Jung Dug Yang, Jeeyeon Lee, Joon Seok Lee

Pageof 2

Frequent Collaborators

6 joint publications

Hyun-Ah Kim

5 joint publications

Min-Ki Seong

5 joint publications

In-Chul Park

4 joint publications

Woo Chul Noh